This story originally appeared in Biocommerce Week, a newsletter that has been discontinued.
Sales from recently acquired Molecular Devices helped MDS Analytical Technologies post a 54 percent gain in second-quarter revenue year over year.
While MDS officials said they were pleased with Molecular Devices’ performance in the quarter, they reiterated their earlier revenue guidance of $190 million for the acquired business during MDS’ first full year of ownership.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.